TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer
Journal of Clinical Oncology - United States
doi 10.1200/jco.2010.34.5579
Full Text
Open PDFAbstract
Available in full text
Date
July 20, 2012
Authors
Publisher
American Society of Clinical Oncology (ASCO)